BMO Capital Markets highlighted the potential risks faced by Real Estate Investment Trusts (REITs) specializing in Skilled Nursing Facilities (SNFs) due to possible changes in Federal Medical ...

BMO Capital Markets reaffirmed their Outperform rating on Beam Therapeutics Inc (NASDAQ:BEAM), with a steady price target of $57.00. Currently trading at $26.57, the stock appears undervalued ...

BMO Capital downgraded Q32 Bio (QTTB) to Market Perform from Outperform with a price target of $3, down from $22. The company announced an ...

February 11, 2025, 03:39 AM ET, BY Momei, Contributor, Stock Traders Daily | Editor: Derek Curry ( Follow on LinkedIn ) ...

February 11, 2025, 12:46 AM ET, BY Christie, Contributor | Editor: Derek Curry ( Follow on LinkedIn ) ...

Bank of Montreal closed 3.6% below its 52-week high of C$147.54, which the company reached on December 6th.

Trading options requires answering these questions: Which direction will a stock move, how far will it go and when will it happen? Here are 4 steps to get started. Many, or all, of the products ...

Peter Gratton, M.A.P.P., Ph.D., is a New Orleans-based editor and professor with over 20 years of experience in investing, risk management, and public policy. Peter began covering markets at ...

PFO offers a 6.62% yield, but it underperforms compared to its peers in both yield and total return. Click here to find out ...